Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer (NSCLC) Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04166487
What this trial is testing

Plasma-Adapted First-Line Pembro In NSCLC

Who this might be right for
NSCLC Stage IVMetastatic Non-Small Cell Lung Cancer
Julia K. Rotow, MD 40
Testing effectiveness (Phase 2)Ended earlyNCT02179567
What this trial is testing

Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC

Who this might be right for
NSCLC
Hellenic Oncology Research Group 26
Not applicableStudy completedNCT04154163
What this trial is testing

Appropriate Dosing to Optimise Personalised Cancer Treatments

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVOvarian Cancer+3 more
University of Dundee 18
Testing effectiveness (Phase 2)Study completedNCT00400829
What this trial is testing

E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00570401
What this trial is testing

Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340309
What this trial is testing

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8+8 more
University of Southern California 5
Not applicableUnknownNCT03258671
What this trial is testing

IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung
LuBing 160
Not applicableStudy completedNCT01026467
What this trial is testing

Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Wake Forest University Health Sciences 45
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Not applicableStudy completedNCT03960034
What this trial is testing

Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications

Who this might be right for
NSCLC Stage IV
Instituto do Cancer do Estado de São Paulo 60
Testing effectiveness (Phase 2)UnknownNCT04767009
What this trial is testing

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Fudan University 59
Large-scale testing (Phase 3)Study completedNCT03302234
What this trial is testing

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 568
Testing effectiveness (Phase 2)Active Not RecruitingNCT02638090
What this trial is testing

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 120
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT00601796
What this trial is testing

Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableEnded earlyNCT04289259
What this trial is testing

Tumor Mutational Burden in Lung Cancer Patients

Who this might be right for
Non Small Cell Lung CancerNon-Small Cell Carcinoma of LungNon Small Cell Lung Cancer Stage III+1 more
Assistance Publique - Hôpitaux de Paris 6
Testing effectiveness (Phase 2)Study completedNCT03971474
What this trial is testing

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
SWOG Cancer Research Network 166
Testing effectiveness (Phase 2)UnknownNCT05055583
What this trial is testing

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

Who this might be right for
NSCLC Stage IVOligometastasis
Tang-Du Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04238169
What this trial is testing

Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer Stage IV
Xinqiao Hospital of Chongqing 60
Next Page